Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ

Connor J Kinslow; James B Yu; David M DeStephano; Lisa A Kachnic; Simon K Cheng; Alfred I Neugut; David P Horowitz

doi:10.1001/jamasurg.2023.0262

Risk of Squamous Cell Carcinoma of the Breast Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Carcinoma in Situ

JAMA Surg. 2023 Jul 1;158(7):769-771. doi: 10.1001/jamasurg.2023.0262.

Authors

Connor J Kinslow^{1

2}, James B Yu^{1

2}, David M DeStephano^{1

2}, Lisa A Kachnic^{1

2}, Simon K Cheng^{1

2}, Alfred I Neugut^{2

3

4}, David P Horowitz^{1

2}

Affiliations

¹ Department of Radiation Oncology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
² Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
³ Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
⁴ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.

No abstract available

Plain language summary

This cohort study uses national surveillance data to describe the incidence and risk of squamous cell carcinoma after postmastectomy implant reconstruction in women with breast cancer.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Breast / surgery
Breast Implants* / adverse effects
Breast Neoplasms* / pathology
Breast Neoplasms* / surgery
Carcinoma in Situ* / surgery
Carcinoma, Squamous Cell* / surgery
Female
Humans
Mammaplasty* / adverse effects
Mastectomy

Grants and funding

P30 CA013696/CA/NCI NIH HHS/United States